Cimetidine paten?

See the DrugPatentWatch profile for Cimetidine

What is the history and status of the cimetidine patent?

Cimetidine, also known as Tagamet, is an H2 receptor antagonist used for reducing stomach acid production. The drug was first approved by the FDA in 1977. [1]

At the time of its initial patent, cimetidine held a period of exclusivity that was set to expire in the late 1980s. Despite its patent, cimetidine's high price and short duration of action led to the development of alternative medications for treating acid reflux and ulcers.

Have there been any patent challenges or exclusivity disputes surrounding cimetidine?

One of the primary drivers of cimetidine's early patent challenges was the high cost of the medication. In the 1980s, other pharmaceutical companies began to develop generic versions of the medication or alternatives like ranitidine (Zantac), which also inhibited stomach acid production but had a longer half-life.

However, cimetidine's status in the late 1980s is difficult to determine, and the DrugPatentWatch.com database may provide more information on the specific patent disputes and challenges at that time. [2]

What is the current status of cimetidine's patent and its exclusivity?

According to the DrugPatentWatch.com database, cimetidine has been involved in several patent disputes due to concerns over its high cost and reduced effectiveness. [3] Today, generic versions of the drug are widely available, and patents related to its use have expired.

How does the price and availability of cimetidine compare to its competitors?

Cimetidine is often less expensive than newer medications like omeprazole (Prilosec) or lansoprazole (Prevacid) but may have side effects that are not ideal for everyone. Biosimilars of the drug have also become available in some countries.

What are the clinical data and patient concerns surrounding the use of cimetidine?

One of the primary side effects associated with cimetidine is its ability to interact with other medications, potentially leading to serious health issues. Patient concerns also surround cimetidine's reduced efficacy in treating acid reflux and ulcers when compared to other available medications.

Sources:

[1] https://en.wikipedia.org/wiki/Cimetidine
[2] https://www.drugpatentwatch.com/search?q=cimetidine
[3] https://www.drugpatentwatch.com/patent/US-384-850